| アブストラクト | Recently, there is a worldwide tendency to decrease medical costs, and a medical insurance revolution, such as a diagnosis procedure combination system, has also been put forward in Japan. It is important to consider medical management healthily by shortening hospital stays and cutting the cost of admission therapies. In this background, outpatients' chemotherapy takes notice because of the improvement in quality of life, discovery of new drugs without severe adverse effects, use-effectiveness of hospital beds and medical cost-effectiveness. Cancer patients suffer from not only a major burden of the diseases such as their physical and mental state, but also an economic impact. In this article, we review the medical cost-benefit for outpatients undergoing cancer chemotherapy. |
|---|
| ジャーナル名 | Journal of UOEH |
|---|
| Pubmed追加日 | 2006/6/20 |
|---|
| 投稿者 | Uramoto, Hidetaka; Iwashige, Atsushi; Kagami, Seiji; Tsukada, Junichi |
|---|
| 組織名 | Cancer Chemotherapy Center, University Hospital, University of Occupational and;Environmental Health, Japan. Yahatanishi-ku, Kitakyushu 807-8555, Japan. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/16780229/ |
|---|
